Abstract
We demonstrate a metal-free catalytic process for the synthesis of anti-HIV drug efavirenz in 99 % ee, which was achieved by an organocatalyzed enantioselective trifluoromethylation with Me3SiCF3 as a key reaction. The combination of cinchona alkaloid-derived phase-transfer catalysts modified with long chain ethers and tetramethylammonium fluoride enables the enantioselective trifluoromethylation of 1-(5-chloro-2-nitrophenyl)-3-cyclopropylprop-2-yn-1-one to be improved, and provides a desired (S)-trifluoromethyl carbinol, which is a two-step key precursor for the synthesis of efavirenz, in up to 80 % ee. As our method is a metal-free process, it would provide an alternative industrial manufacturing process for efavirenz.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
